Astellas Pharma Inc.
[WKN: 856273 | ISIN: JP3942400007]
Aktienkurse
9,131€ 1,89%
Echtzeit-Aktienkurs Astellas Pharma Inc.
Bid: Ask:

Echtzeit-Chart der Astellas Pharma Inc. Aktie

Astellas Pharma Inc. Chart

Charttool öffnen

Börsenkurse Astellas Pharma Inc.

Börse Stuttgart - - - - 9,131€ 0,72%
Börse Frankfurt - - - - 9,060€ 0,64%
gettex - - - - 9,147€ 0,07%
Tradegate - - - - 9,134€ 0,76%
Lang & Schwarz - - - - 9,116€ 0,57%
Echtzeit Euro - - - - 9,131€ 1,89%

Profil der Astellas Pharma Inc. Aktie

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.